These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7861918)

  • 1. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project--II. Reaction and neuritis during and after MDT in PB and MB leprosy patients.
    de Rijk AJ; Gabre S; Byass P; Berhanu T
    Lepr Rev; 1994 Dec; 65(4):320-32. PubMed ID: 7861918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field evaluation of WHO-MDT of fixed duration at ALERT, Ethiopia: the AMFES project--I. MDT course completion, case-holding and another score for disability grading.
    de Rijk AJ; Gabre S; Byass P; Berhanu T
    Lepr Rev; 1994 Dec; 65(4):305-19. PubMed ID: 7861917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.
    Richardus JH; Finlay KM; Croft RP; Smith WC
    Lepr Rev; 1996 Dec; 67(4):297-305. PubMed ID: 9033200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome.
    Saunderson P; Gebre S; Desta K; Byass P; Lockwood DN
    Lepr Rev; 2000 Sep; 71(3):285-308. PubMed ID: 11105488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
    Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
    Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ALERT MDT Field Evaluation Study (AMFES): a descriptive study of leprosy in Ethiopia. Patients, methods and baseline characteristics.
    Saunderson P; Gebre S; Desta K; Byass P
    Lepr Rev; 2000 Sep; 71(3):273-84. PubMed ID: 11105487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of relapse in leprosy after fixed-duration multidrug therapy.
    Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of neuritis among paucibacillary leprosy patients during treatment and surveillance.
    John AS
    Indian J Lepr; 2004; 76(3):215-22. PubMed ID: 15835606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with impairments in new leprosy patients: the AMFES cohort.
    Meima A; Saunderson PR; Gebre S; Desta K; van Oortmarssen GJ; Habbema JD
    Lepr Rev; 1999 Jun; 70(2):189-203. PubMed ID: 10464437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy.
    Sharma P; Kar HK; Beena KR; Kaur H; Narayan R
    Indian J Lepr; 1996; 68(2):127-36. PubMed ID: 8835580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments in multibacillary leprosy; a study from Brazil.
    Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
    Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors.
    Saunderson P; Gebre S; Byass P
    Lepr Rev; 2000 Sep; 71(3):309-17. PubMed ID: 11105489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
    Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
    De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
    Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.